Shares of Natco Pharma jumped nearly 5% to Rs 1,569 in Friday’s intraday trade on BSE after the firm submitted a product application with the US health regulator for a generic product indicated for the treatment of metastatic non-small cell lung cancer. The company has submitted an abbreviated new drug application (ANDA) containing a paragraph … Read more
Brokerage Nomura maintained a neutral rating on Persistent Systems, Investec maintained a buy on Natco Pharma and initiated a buy on Entero Healthcare. CLSA downgraded RIL to outperform. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Nomura on Persistent Systems: Neutral| Target Rs 3400 Nomura maintained a … Read more
There are a host of corporate actions scheduled for this week. Natco Pharma, Suprajit Engineering, NMDC, and Jupiter Wagons will trade ex-dividend, while The South Indian Bank’s rights issue’s ex-date is fixed this week. On Monday, 26th February, Fineotex Chemical (Rs 1.2/share), Gateway Distriparks (Rs 0.75/share), Natco Pharma (Rs 1.25/share), Suprajit Engineering (Rs 1.1/share), and … Read more
